Edwards Lifesciences Corp

EW: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
@P^LOCK|dbsRyLOCK|?>$%sf!^

Edwards Lifesciences Earnings: Strong Performance Puts Firm on Track to Meet Our 2026 Expectations

Edwards delivered second-quarter performance that included $1.74 billion in revenue, up 13% in constant currency, fueled by transcatheter aortic valve replacement growth of 11% and strong double-digit growth in transcatheter mitral and tricuspid.

Sponsor Center